John Chalmers AC's Publications

About John Chalmers AC's Publications

Senior Director, Professorial Unit, The George Institute (Australia)
  • Professor of Medicine, UNSW Sydney
  • Emeritus Professor of Medicine at Flinders University and at the University of Sydney
  • FAA,
  • FAHMS,
  • FRACP

  • Healthy lifestyle factors and combined macrovascular and microvascular events in diabetes patients with high cardiovascular risk: results from ADVANCE

    BMC Medicine Date published:

  • Subacute Neurological Improvement Predicts Favorable Functional Recovery After Intracerebral Hemorrhage: INTERACT2 Study

    Stroke Date published:

  • Effect of randomised blood pressure lowering treatment and intensive glucose control on dementia and cognitive decline according to baseline cognitive function and other subpopulations of individuals with type 2 diabetes: Results from the ADVANCE trial

    Cerebral Circulation - Cognition and Behavior Date published:

  • Intensive Glucose Lowering and Its Effects on Vascular Events and Death According to Age at Diagnosis and Duration of Diabetes: The ADVANCE Trial

    Diabetes Care Date published:

  • Patterns and Clinical Implications of Hemorrhagic Transformation After Thrombolysis in Acute Ischemic Stroke

    Neurology Date published:

  • Influence of renal function on blood pressure control and outcome in thrombolyzed patients after acute ischemic stroke: post-hoc analysis of the ENCHANTED trial

    Frontiers in Endocrinology Date published:

  • blood pressure-lowering and risk of cancer: an individual participant-level data meta-analysis and mendelian randomisation studies

    European Heart Journal Date published:

  • Twenty-Four-Hour Post-Thrombolysis NIHSS Score As the Strongest Prognostic Predictor After Acute Ischemic Stroke: ENCHANTED Study

    Journal of the American Heart Association Date published:

  • Lipids and apolipoproteins and the risk of vascular disease and mortality outcomes in women and men with type 2 diabetes in the ADVANCE study

    Diabetes, Obesity and Metabolism Date published:

  • Combination blood pressure lowering therapy in patients with type 2 diabetes: messages from the ADVANCE trial

    Journal of Hypertension Date published:

  • Randomised controlled decentralised feasibility trial of a fixed low-dose combination antihypertensive drug strategy to attenuate cognitive decline in high-risk adults

    BMJ Open Date published:

  • Prescription and dispensing duration of medicines for hypertension and other chronic conditions: a review of international policies and evidence to inform the Australian setting

    Hypertension Research Date published:

  • Predictors of early versus delayed neurological deterioration after thrombolysis for ischemic stroke: ENCHANTED study

    Cerebrovascular Diseases Date published:

  • A GENETIC RISK SCORE OF EARLY-ONSET TYPE 2 DIABETES PREDICTS EARLY DEATH AND BENEFITS OF INTENSIVE GLYCEMIC CONTROL IN ADVANCE TRIAL

    Journal of Hypertension Date published:

  • SEX DIFFERENCES IN A CARDIOVASCULAR DISEASE RISK SCORE AND ITS COMPONENTS AS PREDICTORS FOR MULTIMORBIDITY IN THE UK BIOBANK

    Journal of Hypertension Date published:

  • Haptoglobin Phenotype and Intensive Glycemic Control for Coronary Artery Disease Risk Reduction in People With Type 2 Diabetes: The ADVANCE Study

    Diabetes Care Date published: